What are G-CSF agonist drugs?

G-CSF agonist drugs are pharmacologic agents that share a common mechanism (typically targeting G-CSFR). 0 are currently marketed, with 6 more in clinical development.

G-CSF agonist

0 marketed 4 in Phase 3 2 in Phase 2

This page covers all G-CSF agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting G-CSFR, G-CSF receptor.

Targets

G-CSFR · G-CSF receptor

Phase 3 pipeline (4)

Peg-filgrastim · Asan Medical Center · Oncology
Peg-filgrastim stimulates the production of white blood cells, specifically neutrophils, to help the body fight infection.
ﬁlgrastim and pegylated filgrastim · Chinese Academy of Medical Sciences · Oncology
Filgrastim and pegylated filgrastim stimulate the production of white blood cells, specifically neutrophils, to help the body fight infection.
pegylated filgrastim and ﬁlgrastim · Chinese Academy of Medical Sciences · Oncology
Pegylated filgrastim and filgrastim stimulate the production of white blood cells, specifically neutrophils, to help the body fight infection.
YPEG-rhG-CSF · Xiamen Amoytop Biotech Co., Ltd. · Oncology
PEG-rhG-CSF is a recombinant human granulocyte colony-stimulating factor (G-CSF) conjugated with polyethylene glycol (PEG), which helps stimulate the production of white blood cells.

Phase 2 pipeline (2)

Injection of Filgrastim · Centre Leon Berard · Oncology
Filgrastim stimulates the production of white blood cells, specifically neutrophils, to help the body fight infection.
Filgrastim Injectable Product · Recardio, Inc. · Oncology
Stimulates the production of white blood cells by binding to and activating the G-CSF receptor.